Proton Radiation for Chordomas and Chondrosarcomas
Phase NA Completed
54 enrolled 11 charts
PRIMHADRON
Completed
62 enrolled
Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection
Completed
62 enrolled
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Phase 1 Completed
184 enrolled 20 charts
ImmunoSarc
Phase 1/2 Completed
197 enrolled
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase 2 Completed
78 enrolled 11 charts
Osteosarcoma
Phase 2 Completed
32 enrolled 11 charts
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Phase 2 Completed
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
Phase 2 Completed
47 enrolled 10 charts
Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
Phase 1/2 Completed
21 enrolled 33 charts
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Phase 1/2 Completed
24 enrolled 14 charts
Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors
Phase 2 Completed
20 enrolled 15 charts
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Phase 1/2 Completed
78 enrolled 11 charts
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
Phase 2 Completed
20 enrolled 10 charts
Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use
Phase NA Completed
56 enrolled
A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
Phase 2 Completed
72 enrolled
CH01
Completed
189 enrolled
Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
Phase 1/2 Completed
381 enrolled
High-dose ICE With Amifostine
Phase 2 Completed
24 enrolled
CONDRO1
Completed
102 enrolled
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Phase 2 Completed
185 enrolled
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Phase 1/2 Completed
70 enrolled
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Phase 2 Completed
53 enrolled 6 charts
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
121 enrolled
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
Phase 2 Completed
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Alanosine in Treating Patients With Cancer
Phase 2 Completed
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
Phase 1 Completed
60 enrolled
IPI-926 Extension Protocol for Continuation of Treatment With IPI-926
Phase NA Completed
9 enrolled
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Phase 2 Completed
54 enrolled 8 charts
S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
Phase 2 Completed
60 enrolled
S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
Phase 2 Completed
75 enrolled
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1 Completed
26 enrolled